Highly expressed Claudin18.2 as a potential therapeutic target in advanced gastric signet-ring cell carcinoma (SRCC).
J Gastrointest Oncol. 2020 Dec;11(6):1431-1439. doi: 10.21037/jgo-20-344.
J Gastrointest Oncol. 2020.
PMID: 33457012
Free PMC article.